Glen Eagle Advisors’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15
| Closed | -$781 | – | 1030 |
|
|
2023
Q2 | $781 | Hold |
15
| – | – | ﹤0.01% | 977 |
|
|
2023
Q1 | $813 | Hold |
15
| – | – | ﹤0.01% | 969 |
|
|
2022
Q4 | $866 | Hold |
15
| – | – | ﹤0.01% | 1036 |
|
|
2022
Q3 | $715 | Hold |
15
| – | – | ﹤0.01% | 1000 |
|
|
2022
Q2 | $726 | Hold |
15
| – | – | ﹤0.01% | 922 |
|
|
2022
Q1 | $930 | Hold |
15
| – | – | ﹤0.01% | 875 |
|
|
2021
Q4 | $1.22K | Buy |
+15
| New | +$1.22K | ﹤0.01% | 852 |
|